The global next generation sequencers market is to increase from US$ XX.X million in 2020 to US$ XX.X million by 2025. The market is estimated to grow with a compound annual growth rate (CAGR) of XX.X% (2020-2025). Some of the prominent players in the market are BGI (China), Eurofins Scientific (Luxembourg), Illumina, Inc. (US), Macrogen Inc. (South Korea), Otogenetics Corporation (US), Oxford Nanopore Technologies, Ltd. (UK), Pacific Biosciences of California, Inc. (US), QIAGEN N. V. (Germany), Roche Holding AG (Switzerland), Thermo Fisher Scientific, Inc. (US). The research report on the global next generation sequencers market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other information specific to the market.
The global economy is highly affected by the COVID-19. Various sectors in the economy are much affected by this pandemic. The global economy will decline because of the loss of trillions of dollars. The growing extension and imposition of lockdown in various countries directly affect the economy all over the world. The report consists of a chapter that provides a detailed study of the impact of COVID-19 on the next generation sequencers market. This report is helpful for business and industry practitioners. The study specifically intended to assist in explaining, directing, and understanding the potential of the next generation sequencers markets. The study focuses on providing readers with an understanding of developments in the industry. The report also provides detailed insights on market segments, market forecasts, leading players, market drivers, and inhibitors.
The second chapter, market overview, provides an overview of the next generation sequencers market. The chapter discusses macroeconomic factors, drivers, restraints, opportunities, challenges, value chain analysis, technology roadmap, and Porter 5 force model analysis.
Chapter 3, segment analysis provides information on the different sub-segments of the market. The chapter provides an in-depth analysis of the market segments, year-on-year growth projections that enable readers to identify potential market growth areas.
Chapter 4, the regional analysis includes an in-depth analysis of the next generation sequencers market by region. The chapter includes various regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The report also includes a comprehensive analysis of the market by country. The report covers countries such as the United States, Canada, Germany, France, Italy, Spain, China, India, Japan, the GCC, South Africa, Brazil, Mexico, and the rest of the world. Regional insight helps market competitors to make crucial decisions about their company. Individualized, country-wise, and segment-wise analyses by region allow readers to explore the potential of the market in different geographies. This section is a vital part of the report for each year's growth projections and a global share of value.
Chapter 5, competitive analysis of the report includes company shares analysis, a list of acquisitions, mergers, collaboration, and the introduction of new products.
Chapter 6, the company profile of the report also covers key industry players working in the next generation sequencers market. The report also discusses the business strategies adopted by the players at the global, regional, and country-level. The study also focuses on various businesses or inorganic business development strategies for expanding consumer networks through product formation, organization extension, partnerships, mergers, and acquisitions.
The study offers an exhaustive summary and estimate of the global market. It includes in-depth qualitative and quantitative analyses in the report that align with our customer's goals and objectives. Projections have been confirmed by comprehensive primary and secondary analysis. The study will encourage clients to invest in the market based on the current business situation, trends, and potential developments in the segments. Understanding the requirement of the client, the report delivers specialist insights into the global market, its products, and market patterns.
1. Introduction
2. Market Overview
2.1. Global Next Generation Sequencers Market Introduction
2.2. Macro- Economic Factor
2.3. Market Determinants
2.3.1. Market Driver
2.3.2. Market Restraints
2.3.3. Market Opportunities
2.3.4. Market Challenges
2.4. Technology/Product Roadmap
2.5. PEST Analysis
2.6. Market Growth Opportunity Analysis
2.7. Impact of Covid-19 on Next Generation Sequencers Market
3. Market Segmentation
3.1. Global Next Generation Sequencers Market Analysis (US$ Mn), By Type, 2019 - 2025
3.1.1 Sequencing by Synthesis (SBS)
3.1.2 Ion Semiconductor Sequencing
3.1.3 Sequencing by Ligation (SBL)
3.1.4 Pyrosequencing
3.1.5 Single-Molecule Real-time (SMRT) Sequencing
3.1.6 Other
3.2. Global Next Generation Sequencers Market Analysis (US$ Mn), By Application, 2019 - 2025
3.2.1 Diagnostics
3.2.2 Drug Discovery
3.2.3 Biomarker Discovery
3.2.4 Personalized Medicine
3.2.5 Agriculture and Animal Research
3.2.6 Others
4. Regional Analysis
4.1. North America Next Generation Sequencers Market Analysis (US$ Mn), 2019 - 2025
4.1.1. By Country
4.1.1.1. U.S.
4.1.1.2.Canada
4.1.2.By Type
4.1.3.By Application
4.2.Europe Next Generation Sequencers Market Analysis (US$ Mn), 2019 - 2025
4.2.1.By Country
4.2.1.1.Germany
4.2.1.2.U.K.
4.2.1.3.France
4.2.1.4.Italy
4.2.1.5.Spain
4.2.1.6.Rest of Europe
4.2.2.By Type
4.2.3.By Application
4.3.Asia Pacific Next Generation Sequencers Market Analysis (US$ Mn), 2019 - 2025
4.3.1.By Country
4.3.1.1.China
4.3.1.2.Japan
4.3.1.3.India
4.3.1.4.Rest of Asia Pacific
4.3.2.By Type
4.3.3.By Application
4.4.Rest of world Next Generation Sequencers Market Analysis (US$ Mn), 2019 - 2025
4.4.1. By Region
4.4.1.1. Middle East & Africa
4.4.1.2. Latin America
4.4.2.By Type
4.4.3. By Application
5.Company Profiles
5.1 BGI (China)
5.2 Eurofins Scientific (Luxembourg)
5.3 Illumina, Inc. (US)
5.4 Macrogen Inc. (South Korea)
5.5 Otogenetics Corporation (US)
5.6 Oxford Nanopore Technologies, Ltd. (UK)
5.7 Pacific Biosciences of California, Inc. (US)
5.8 QIAGEN N. V. (Germany)
5.9 Roche Holding AG (Switzerland)
5.10 Thermo Fisher Scientific, Inc. (US)